Matches in Wikidata for { <http://www.wikidata.org/entity/Q90319621> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q90319621 description "articolo scientifico (pubblicato il 2019)" @default.
- Q90319621 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q90319621 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q90319621 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90319621 description "scientific article published on 01 February 2019" @default.
- Q90319621 description "wetenschappelijk artikel" @default.
- Q90319621 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q90319621 name "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 name "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 name "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 type Item @default.
- Q90319621 label "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 label "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 label "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 prefLabel "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 prefLabel "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 prefLabel "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 P1433 Q90319621-405E707A-2FE4-4C03-9702-7CB627888AC0 @default.
- Q90319621 P1476 Q90319621-C502AF50-5786-4596-8C39-7F795C006624 @default.
- Q90319621 P2093 Q90319621-457A03F8-9335-48BF-B798-6A011E22F045 @default.
- Q90319621 P2093 Q90319621-4AC53145-5584-4E7F-BD5F-76F3E6A6FF9D @default.
- Q90319621 P2093 Q90319621-4BA7A607-4795-459B-9028-FCF75FFA5916 @default.
- Q90319621 P2093 Q90319621-569DDE46-B70F-462C-B3BE-0E669C9D9AB0 @default.
- Q90319621 P2093 Q90319621-56B95A66-2A35-40D7-84D1-2434D0C65893 @default.
- Q90319621 P2093 Q90319621-74F2BC7A-A5BD-4420-BC5E-21E1EA1C4D8E @default.
- Q90319621 P2093 Q90319621-9EBF340D-C8DC-46FC-94A2-A251509BD81C @default.
- Q90319621 P2093 Q90319621-D4B2C57C-E73E-4FB8-8841-7A9638FD1E95 @default.
- Q90319621 P304 Q90319621-86A8FA44-A940-46B0-9470-F218CA8100B5 @default.
- Q90319621 P31 Q90319621-12448D7A-DFFA-4018-845F-C552C0518AFA @default.
- Q90319621 P31 Q90319621-8317FB14-58F6-49DF-B454-7A0FB2F33F21 @default.
- Q90319621 P356 Q90319621-5F915490-04D9-425F-A842-0F3FE4010EF7 @default.
- Q90319621 P433 Q90319621-BC2D5ABE-7CBA-4AE7-9BEB-00762D09F723 @default.
- Q90319621 P478 Q90319621-C5759FFC-9344-4890-9956-E9057F48165C @default.
- Q90319621 P50 Q90319621-59847072-5213-476D-826F-23EB99F1D04A @default.
- Q90319621 P50 Q90319621-D2DEC057-9AEC-4DC5-90D8-283D0E737BD5 @default.
- Q90319621 P577 Q90319621-1888882E-E298-4F3D-958D-01B07A990F35 @default.
- Q90319621 P698 Q90319621-4C08EA2C-2A44-4D41-B469-0BB39FFDC868 @default.
- Q90319621 P921 Q90319621-1127060C-7844-4A1A-960D-DB40CAEFE94B @default.
- Q90319621 P932 Q90319621-23D82B25-A4A0-42E2-8F4E-9F7E156CBA0D @default.
- Q90319621 P356 S13300-018-0546-6 @default.
- Q90319621 P698 30523582 @default.
- Q90319621 P1433 Q26853803 @default.
- Q90319621 P1476 "Correction to: Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol" @default.
- Q90319621 P2093 "Andreas L Birkenfeld" @default.
- Q90319621 P2093 "Carsta Köhler" @default.
- Q90319621 P2093 "Christoph Hasslacher" @default.
- Q90319621 P2093 "Christoph Schindler" @default.
- Q90319621 P2093 "Diethelm Tschöpe" @default.
- Q90319621 P2093 "Martin Grüneberg" @default.
- Q90319621 P2093 "Stefan R Bornstein" @default.
- Q90319621 P2093 "Ulrike Schatz" @default.
- Q90319621 P304 "329-331" @default.
- Q90319621 P31 Q13442814 @default.
- Q90319621 P31 Q1348305 @default.
- Q90319621 P356 "10.1007/S13300-018-0546-6" @default.
- Q90319621 P433 "1" @default.
- Q90319621 P478 "10" @default.
- Q90319621 P50 Q15431947 @default.
- Q90319621 P50 Q51732471 @default.
- Q90319621 P577 "2019-02-01T00:00:00Z" @default.
- Q90319621 P698 "30523582" @default.
- Q90319621 P921 Q3025883 @default.
- Q90319621 P932 "6349274" @default.